Take Two: Inflation eases in US and China, UK hikes rates again
- 15 May 2023 (3 min read)
What do you need to know?
US annual inflation eased for a 10th consecutive month in April, falling to 4.9% from 5% in March – its lowest level in two years, following a series of interest rate rises from the Federal Reserve (Fed). Meanwhile, core inflation, excluding food and energy, slowed to 5.5% from 5.6% in March, potentially making room for the Fed to pause its rate hiking cycle in June. In China, the Consumer Price Index rose 0.1% year-on-year from 0.7% in March, the lowest since February 2021. However, this reflects lacklustre demand in the world’s second largest economy, and the potential need for greater economic stimulus to drive its post-pandemic recovery.
Around the world
Eurozone consumers have become more pessimistic about inflation and see prices rising at an annual rate of 5% in a year’s time, according to a March survey from the European Central Bank (ECB) – versus 4.6% in the previous survey. Hardened expectations could help dissuade the ECB from pausing its rate-hiking cycle, an idea supported by comments from ECB President Christine Lagarde who said during the week that “the fight is not over”. The Bank of England raised rates again, hiking by 25 basis points to 4.5%. It raised its forecast for UK GDP over the coming three years by the most in its history and now no longer predicts a recession this year. Official GDP data the following day showed growth of 0.1% for the first quarter (Q1), including an unexpected 0.3% contraction in March.
Figure in focus: 1,206
The number of mutual funds and exchange-traded funds with a climate-related mandate reached a record 1,206 at the end of 2022, up from 950 the year before, according to investment research firm Morningstar. These funds had about $415bn of assets under management, and proved more resilient than the broader market, declining 1.4% in 2022 compared to an 18% fall in global fund assets.[1] Europe was the largest and most diverse market for climate-related funds, followed by China, which overtook the US two years ago, Morningstar said. It also expects the US Inflation Reduction Act to spur an increase in the number of climate-related funds this year.
Words of wisdom: Pangenome
A new, more diverse map of the human genetic code based on information from 47 people from Africa, Asia, the Americas and Europe – 20 years after the completion of the original human genome project that was based on the DNA of only one person. The new pangenome, by including a broader sample of the global population, could enhance scientific knowledge around genetic variation as well as complex human conditions and diseases – potentially leading to the creation of new drugs and treatments for a wider range of people.
What’s coming up
On Tuesday, China reports its unemployment rate for April, and the Reserve Bank of Australia publishes the minutes from its latest monetary policy meeting, where it increased its cash rate by 25 basis points to 3.85%. Elsewhere Canada announces fresh inflation data while the Eurozone posts a second estimate for Q1 GDP growth; the initial forecast came in at 1.3% year-on-year. Japan follows with its own preliminary Q1 GDP growth estimate on Wednesday, when the Eurozone also confirms its final inflation numbers for April. Australia announces its unemployment numbers on Thursday and Japan follows with inflation data on Friday.
[1] Source: Morningstar. Past performance does not guarantee future returns.
Disclaimer
This website is published by AXA Investment Managers Asia Limited (“AXA IM HK”), an entity licensed by the Securities and Futures Commission of Hong Kong (“SFC”), for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy, sell or enter into any transactions in respect of any investments, products or services, and should not be considered as solicitation or investment, legal, tax or any other advice, a recommendation for an investment strategy or a personalised recommendation to buy or sell securities under any applicable law or regulation. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation, investment knowledge or particular needs of any particular person and may be subject to change at any time without notice. Offering may be made only on the basis of the information disclosed in the relevant offering documents. Please consult independent financial or other professional advisers if you are unsure about any information contained herein.
Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee such opinions, estimates and forecasts made will come to pass. Actual results of operations and achievements may differ materially. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Information herein may be obtained from sources believed to be reliable. AXA IM HK has reasonable belief that such information is accurate, complete and up-to-date. To the maximum extent permitted by law, AXA IM HK, its affiliates, directors, officers or employees take no responsibility for the data provided by third party, including the accuracy of such data. This material does not contain sufficient information to support an investment decision. References to companies (if any) are for illustrative purposes only and should not be viewed as investment recommendations or solicitations.
All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and that past performance is no guarantee of future returns, investors may not get back the amount originally invested. Investors should not make any investment decision based on this material alone.
Some of the services listed on this Website may not be available for offer to retail investors.
This Website has not been reviewed by the SFC. © 2024 AXA Investment Managers. All rights reserved.